Cargando…
Decreased Expression of a Novel lncRNA FAM181A-AS1 is Associated with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma
BACKGROUND: There is no clear information regarding the role of FAM181A antisense RNA 1 (FAM181A-AS1) in lung adenocarcinoma (LUAD). We explored the relationship between FAM181A-AS1 and LUAD using bioinformatics analysis and experimental validation in this study. METHODS: Statistics and databases we...
Autores principales: | Liang, Weiquan, Lu, Yiyu, Pan, Xingxi, Zeng, Yunxiang, Zheng, Weiqiang, Li, Yiran, Nie, Yuanhang, Li, Dongbing, Wang, Dongliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724578/ https://www.ncbi.nlm.nih.gov/pubmed/36482943 http://dx.doi.org/10.2147/PGPM.S384901 |
Ejemplares similares
-
A novel telomere-related gene prognostic signature for survival and drug treatment efficiency prediction in lung adenocarcinoma
por: Chen, Haiming, et al.
Publicado: (2023) -
LncRNA FAM181A-AS1 promotes gliomagenesis by sponging miR-129-5p and upregulating ZRANB2
por: Jiang, Xin, et al.
Publicado: (2020) -
LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma
por: Lin, Zhichao, et al.
Publicado: (2021) -
FAM225B Is a Prognostic lncRNA for Patients with Recurrent Glioblastoma
por: Li, Junsheng, et al.
Publicado: (2020) -
LncRNA FAM83A‐AS1 promotes lung adenocarcinoma progression by enhancing the pre‐mRNA stability of FAM83A
por: Wang, Wenyi, et al.
Publicado: (2021)